Abstract
Introduction Intraoperative ultrasound is becoming a common tool in neurosurgery. However, effective simulation methods are limited. Current, commercial, and homemade phantoms lack replication of anatomical correctness and texture complexity of brain and tumour tissue in ultrasound images. Materials and Methods: We utilise ex-vivo brain tissue, as opposed to synthetic materials, to achieve realistic echogenic complexity and anatomical correctness. Agar, at 10-20% concentrate, is injected into the brain tissue to simulate the tumour mass. A commercially available phantom was purchased for benchmarking.
Results Qualitative analysis is performed by experienced professionals, measuring the impact of the addition of agar and comparing it to the commercial phantom. Overall, the use of ex vivo tissue was deemed more accurate and representative, compared to the synthetic materials-based phantom, as it provided good visualisation of real brain anatomy and good contrast within tissue. The agar tumour correctly produced a region of higher echogenicity with slight diffusion along the margin and expected interaction with the neighbouring anatomy.
Discussion Using human samples for training is limited due to high logistical and ethical challenges. Sparsity of online neurosurgical US data further compounds this. The proposed method successfully produced a better simulation of tumours in brain tissue than the phantom which suffers from surface texture dissimilarity, ultrasound echogenic homogeneity, and lack of anatomical correctness.
Conclusion The proposed method for creating tumour-mimicking tissue in brain tissue is in-expensive, accurate, and simple. Beneficial for both the trainee clinician and the researcher. A total of 576 annotated images are made publicly available upon request. Word count ≈ 3400.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by the UK Research and Innovation (UKRI) Centre for Doctoral Training in AI for Healthcare (EP/S023283/1), the Royal Society (URF$\setminus$R$\setminus$201014), the NIHR Imperial Biomedical Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
